DOSE:CC News and Press, Rapid Dose Therapeutics Corp.

Burlington, Ontario--(Newsfile Corp. - July 22, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (" RDT " or the " Company ") is pleased to announce that it has closed a first tranche of its previously announced equity private placement financing (the " Financing ") for aggregate gross proceeds ...

Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (" RDT " or the " Company ") announced today that as contemplated in the secured convertible notes (the " Notes ") previously issued on its private placement financing (the " Financing "), the Company...

Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (" RDT " or the " Company "), is pleased to announce the filing of its financial results for the year ended February 29, 2024. Mark Upsdell, Chairman and Chief Executive Officer, stated, "Over ...

Burlington, Ontario--(Newsfile Corp. - June 25, 2024) - Rapid Dose Therapeutics Corp . (" RDT " or the " Company ") trading on the Canadian Securities Exchange ("CSE") under the symbol DOSE is pleased to announce the recent award of a Mitacs Accelerate grant, with a value of $30,000 in May 202...

Burlington, Ontario--(Newsfile Corp. - June 19, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (" RDT " or the " Company ") today announced that further to its press release dated May 8, 2024, regarding a proposed equity private placement financing (the " Financing "), the Company has rec...

Burlington, Ontario--(Newsfile Corp. - May 29, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (" RDT " or the " Company ") announces its collaboration in the National Football League (NFL) – funded clinical trial program entitled "Naturally Produced Cannabinoids for Pain Management...

Burlington, Ontario--(Newsfile Corp. - May 22, 2024) - Rapid Dose Therapeutics Corp . (CSE: DOSE) (" RDT " or the " Company ") trading on the Canadian Securities Exchange ("CSE") under the symbol DOSE in partnership with McMaster University ("McMaster") is pleased to announce the publication o...

Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) (CSE: DOSE), today reported its financial results for the year ended February 28, 2023. The Company is pleased to be able to report on its results for the fiscal year 2023 which ended February 28, 2...

Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) (CSE: DOSE) today announced that further to its press release dated June 2, 2023, it plans to complete an increased private placement financing (the “ Financing ”) for up to $5,000,000...

Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) (CSE: DOSE) today announced that it plans to complete a private placement financing (the “ Financing ”) for up to $3,000,000 of gross proceeds, consisting of up to 3,000,000 units (the...